About Alliance Pharma (LON:APH)
Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international. The Company's therapeutic areas of focus include cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology and travel health. The Company's product categories include prescription only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements. The Company's products include SkinSafe, Lift Plus, AbsorbaGel, DeoGel, LaVera, ClearWay, Gelclair, ImmuCyst 81mg, Hydromol, MacuShield, Lypsyl, Anbesol Adult Strength Gel, MolluDab and Ashton & Parsons Infants' Powders.
Industry, Sector and Symbol
Industry Generic Pharmaceuticals
Trailing P/E Ratio1320
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Trailing EPSGBX 0.05
Return on Equity14.63%
Return on Assets8.39%
Alliance Pharma (LON:APH) Frequently Asked Questions
What is Alliance Pharma's stock symbol?
Alliance Pharma trades on the London Stock Exchange (LON) under the ticker symbol "APH."
How often does Alliance Pharma pay dividends? What is the dividend yield for Alliance Pharma?
Alliance Pharma declared a dividend on Wednesday, September 13th. Stockholders of record on Thursday, December 21st will be paid a dividend of GBX 0.44 per share on Thursday, January 11th. This represents a dividend yield of 0.84%. The ex-dividend date of this dividend is Thursday, December 21st. The official announcement can be viewed at this link. View Alliance Pharma's Dividend History.
Where is Alliance Pharma's stock going? Where will Alliance Pharma's stock price be in 2018?
3 equities research analysts have issued 1-year price targets for Alliance Pharma's stock. Their forecasts range from GBX 59 to GBX 80. On average, they anticipate Alliance Pharma's share price to reach GBX 69.67 in the next twelve months. View Analyst Ratings for Alliance Pharma.
Who are some of Alliance Pharma's key competitors?
Some companies that are related to Alliance Pharma include Landauer (LDR), American Renal Associates (ARA), Vitae Pharmaceuticals (VTAE), Universal American (UAM), SciClone Pharmaceuticals (SCLN), Abeona Therapeutics (ABEO), R1 RCM (RCM), Theratechnologies (TH), Mesoblast (MESO), Craneware (CRW), Omeros (OMER), Organigram (OGI), Vectura Group (VEC), Arrowhead Pharmaceuticals (ARWR), Agenus (AGEN), Castlight Health (CSLT), Depomed (DEPO) and Synergy Pharmaceuticals (SGYP).
Who are Alliance Pharma's key executives?
Alliance Pharma's management team includes the folowing people:
- John Dawson, Chief Executive Officer, Executive Director
- Andrew Franklin, Finance Director, Director
- Peter Butterfield, Chief Commercial Officer, Executive Director
- Janice Timberlake, Director of Human Resources
- Margaret Boulton, Medical and Regulatory Affairs Director
- Stephen Kidner, Operations Director
- Dan Thomas, Business Development Director
- Sarah Robinson, Company Secretary
- Andrew L. Smith, Non-Executive Chairman of the Board (Age 58)
- Thomas Theodore Casdagli, Non-Executive Director
How do I buy Alliance Pharma stock?
Shares of Alliance Pharma and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Alliance Pharma's stock price today?
One share of Alliance Pharma stock can currently be purchased for approximately GBX 66.
How big of a company is Alliance Pharma?
Alliance Pharma has a market capitalization of £324.95 million.
How can I contact Alliance Pharma?
Alliance Pharma's mailing address is Avonbridge House, Bath Road, CHIPPENHAM, SN15 2BB, United Kingdom. The company can be reached via phone at +44-1249-466966.
MarketBeat Community Rating for Alliance Pharma (APH)MarketBeat's community ratings are surveys of what our community members think about Alliance Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for Alliance Pharma (LON:APH)
No earnings announcements for this company have been tracked by MarketBeat.com
Alliance Pharma (LON:APH) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Alliance Pharma (LON:APH) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Alliance Pharma (LON APH) Insider Trading and Institutional Ownership History
Alliance Pharma (LON APH) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/14/2017||Peter Butterfield||Insider||Sell||61,846||GBX 49||£30,304.54|
|9/22/2016||John Dawson||Insider||Sell||3,000,000||GBX 45||£1,350,000|
|12/17/2015||Smith,Andrew L||Insider||Buy||75,000||GBX 41||£30,750|
|6/16/2015||Nigel Clifford||Insider||Buy||58,227||GBX 39.50||£22,999.67|
Alliance Pharma (LON APH) News Headlines
Alliance Pharma (LON:APH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Alliance Pharma (LON APH) Stock Chart for Wednesday, February, 21, 2018